glp-1 and alzheimer's disease drugs failed to slow in two big clinical trials Neuroprotective Actions of Glucagon-Like Peptide-1

doi: 10.1002/hsr2.71279 58

Although it is not FDA-approved for weight management, clinicians prescribe it for its off-label use

SGLT1 is the transporter in the intestinal cells that allows for the uptake of glucose from the foods youve eaten

Building on this momentum, Wegovy also gained FDA approval for Metabolic Dysfunction-Associated Steatohepatitis (MASH) in 2025

Water-soluble and easy to formulate into modern cosmetic systems

Recent recommendations from the Joint British Diabetes Societies suggest the use of continuous glucose monitors, where available, in patients on dialysis as the best way to monitor glucose control (Figure)